Written Commentary
In honor of World Microbiome Day, ADM spotlights an exceptional member of Team ADM!
Like with any true scientist, for Daniel Ramón Vidal, it all started as an experiment. Gut health, the microbiome and probiotics are making their way into the mainstream lexicon, but these terms are not new for Vidal, ADM’s distinguished research fellow for the microbiome. He’s been a pioneer leading the way for more than 15 years.
Futures and options trading involve significant risk of loss and may not be suitable for everyone. Therefore, carefully consider whether such trading is suitable for you in light of your financial condition. The information and comments contained herein is provided by ADMIS and in no way should be construed to be information provided by ADM. The author of this report did not have a financial interest in any of the contracts discussed in this report at the time the report was prepared. The information provided is designed to assist in your analysis and evaluation of the futures and options markets. However, any decisions you may make to buy, sell or hold a futures or options position on such research are entirely your own and not in any way deemed to be endorsed by or attributed to ADMIS. Copyright ADM Investor Services, Inc.
